@ProcureICO

Program Against Cancer Therapeutic Resistance @ICO_oncologia @idibell_cat @GTRecerca @idibgi @iCERCA @salutcat

[CALL TO ACTIVISM @CalltoActivism]

This is Marco Rubio explaining how the USA promised to defend Ukraine forever if they got rid of their nuclear arsenal left after the Soviet Union fell.

This is why lil marco was sinking into the couch. He was hoping we wouldn’t find it…so don’t RT right now this very second.

[Institut Català d'Oncologia @ICO_oncologia]

La forma de creixement de les #metàstasi hepàtiques de #càncer de còlon podria influir en la resposta a la #immunoteràpia.
Segons un estudi @ICO_oncologia i @idibell_cat aquests resultats són molt rellevants per al disseny de teràpies personalitzades.
https://t.co/QrPT6Ox63v

[IDIBELL @idibell_cat]

🔬Growth pattern in colon cancer liver metastases may influence response to #immunotherapy via their cell microenvironment.
According to #IDIBELL and @ICO_oncologia researchers, the results could have a major impact on treatments personalisation.
🆕https://t.co/ZL5OeL9fcX

[Sdelci Lab @SdelciL]

2 of them in our lab! Apply :)

[Juan Rodriguez Vita @J_RodriguezVita]

We are seeking for a PhD student to work on tumor cell plasticity in ovarian cancer at @CIPFciencia. #CancerResearch

[@ProcureICO @ProcureICO]

@GTRecerca @ICO_oncologia @embalibrea @ElsevierConnect Congrats Eva and team!

[AAytesLab @AAytesLab]

Today we say farewell to two awesome scientists and even better human beings. Thanks Adrian @AdriMTebar and Rana @Eb90Rana. You will be missed but we are also happy for your upcoming endeavors. The @AAytesLab will always carry you in its heart. And, of course come visit us soon!

[@ProcureICO @ProcureICO]

@metabostemness @SaraVerdura @idibgi Congrats @SaraVerdura and Javier @metabostemness!

[Adrián M. Tébar @AdriMTebar]

The @AAytesLab group has celebrated Christmas in advance with a delicious lunch, sharing a fantastic time together and wishing for a new year filled with new opportunities, joy, and success! Have a wonderful holiday with your loved ones! 🎄❤️🎁

[@ProcureICO @ProcureICO]

Way to go Adri! @AdriMTebar

[Adrián M. Tébar @AdriMTebar]

Thrilled to present my results from @AAytesLab at the @EMBO Workshop in Rimini. What a great opportunity to networking!

[IDIBELL @idibell_cat]

La #VIIIMillaBombersBCN dels @BCN_Bombers donarà suport a la recerca en la malaltia minoritària LAM (@ASOCIACIONAELAM) 👏👏👏

Més informació ➡️ https://t.co/fMn55nKHBU

[@ProcureICO @ProcureICO]

Our heartfelt condolences to all the @idibell_cat family. Virginia was above all a truly remarkable human being. May her legacy serve as inspiration.

[IDIBELL @idibell_cat]

Ahir ens va deixar després d'una llarga malaltia una de les fundadores i membres més estimades de l'institut, la Virginia Nunes. És un dia trist per l'IDIBELL i per a mi. Pionera de la Genètica Humana la seva ciència perdurarà. G. Capellá.

[IDIBELL @idibell_cat]

Join us for the third edition of the @oncobellsympo, "New Frontiers in #CancerTherapies and #PersonalizedMedicine," on October 3rd and 4th!

More info ➡️ https://t.co/Add7LDuwON

[Manuel Ansede @manuelansede]

Querida comunidad científica, ¿podéis echarle un ojo a este perfil antes de que lo borren? Un tal Brian Lees, que publica siempre el mismo texto, cambiando solo el título, el lugar y la fecha (de 2001 a 2013). Y siempre con 37 citas a Juan Manuel Corchado:
https://t.co/qqOakdyC9H

[IDIBGI Institut d'Investigació Biomèdica de Girona @idibgi]

‼️👩‍🔬 Nova sessió de seminaris interns #InsideScience de l'IDIBGI! Amb les ponències:

🔹"Biology in cosmic silence: a deep-underground experience" ⛰️🔬
Àngela Llop (IDIBGI - @ProcureICO ) @labsubcanfranc

[IDIBELL @idibell_cat]

📣 New #IDIBELLSeminar
📋 Targeting lineage plasticity in #ProstateCancer
🗣️ Wouter Karthaus @EPFL_en
Hosted by @AAytesLab
🗓️Friday, May 10 - ⏰ 13h

📍 Sala Pau Viladiu @ICO_oncologia
More info ➡️ https://t.co/m70PCooXcD

[@ProcureICO @ProcureICO]

She did a great job!

[Institut Català d'Oncologia @ICO_oncologia]

La reutilització de #medicaments: noves oportunitats per als pacients oncològics.
L’abordatge computacional del reaprofitament de #fàrmacs prediu que un significatiu percentatge del 14% podrien tractar-se amb teràpies ja aprovades.
https://t.co/pL0ueD1KLv

[MAPujana @PujanaLab]

@antolin_aa @Mal_Ameratunga @MonashUni @idibell_cat @ICO_oncologia Nice work Albert & team!
Quite relevant
Go @ProcureICO

[@ProcureICO @ProcureICO]

Join us in congratulating Dr Alvaro Aytes @AAytesLab for his well deserved promotion to senior Group Leader at @idibell_cat continuing with his affiliation to @ProcureICO. Well done, Alvaro!!